Corcept Therapeutics
CORT
#2416
Rank
ยฃ4.82 B
Marketcap
ยฃ46.00
Share price
9.34%
Change (1 day)
119.69%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of November 2024 (TTM): 10.0

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.85. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.28-57.22%๐Ÿ‡บ๐Ÿ‡ธ USA
2.32-76.83%๐Ÿ‡บ๐Ÿ‡ธ USA
4.26-57.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
19.5 94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
2.74-72.64%๐Ÿ‡บ๐Ÿ‡ธ USA
4.18-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
1.62-83.78%๐Ÿ‡บ๐Ÿ‡ธ USA
7.92-20.94%๐Ÿ‡บ๐Ÿ‡ธ USA
4.66-53.45%๐Ÿ‡บ๐Ÿ‡ธ USA